Beutel, Goodman & Co’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Beutel, Goodman & Co's GSK Position: Q3 2026 in Review
Beutel, Goodman & Co reduced its GSK (GSK) stake by 0.71% in Q3 2026, selling an estimated $4.19K and leaving 11,502 shares worth $554K. The position accounts for ﹤0.01% of the portfolio, ranked #111.
Beutel, Goodman & Co first reported a position in GSK in Q3 2019 and has held it in 27 quarters since. The position peaked at $16.7M in Q4 2019. 986 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Beutel, Goodman & Co held 11,502 shares of GSK worth $554K as of Q3 2026.
- Beutel, Goodman & Co sold 82 GSK shares in Q3 2026, an estimated $4.19K.
- GSK made up ﹤0.01% of Beutel, Goodman & Co's portfolio in Q3 2026, its #111 holding.
- Beutel, Goodman & Co first reported a position in GSK in Q3 2019 and has held it in 27 quarters since.
- Beutel, Goodman & Co's GSK position peaked at $16.7M in Q4 2019.
- 986 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Beutel, Goodman & Co's 13F filing for Q3 2026, filed 4 Nov 2026.